Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Protocol of Intensity-Modulated Radiotherapy for Treatment of Previously Irradiated Recurrent Head and Neck Cancer

NCT00257335 is registered in ClinicalTrials.gov with Nilam Ramsinghani as lead sponsor.

NCT NCT00257335
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00257335 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Protocol of Intensity-Modulated Radiotherapy for Treatment of Previously Irradiated Recurrent Head and Neck Cancer
Lead sponsor
Nilam Ramsinghani
Phase
Phase 2
Overall status
Withdrawn
Start date
October 14, 2004
Completion date
June 12, 2007
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma of the head and neck